BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3238662)

  • 1. Mitroflow heart valve: 5.5 years clinical experience.
    Revuelta JM; Bernal JM; Gutierrez JA; Gaite L; Alonso C; Durán CM
    Thorac Cardiovasc Surg; 1988 Oct; 36(5):262-5. PubMed ID: 3238662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Mitroflow bioprosthesis. Results after 6 years].
    Revuelta JM; Bernal JM; Rabasa JM; Alonso C; Lequerica MA; Gutiérrez JA; Gaite L
    Rev Esp Cardiol; 1989 Nov; 42(9):614-9. PubMed ID: 2616845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Ionescu-Shiley pericardial valve in the aortic position: 100 months clinical experience.
    Revuelta JM; Durán CM
    Thorac Cardiovasc Surg; 1986 Aug; 34(4):247-51. PubMed ID: 2429393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
    Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
    J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
    Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
    J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
    Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
    J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
    Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
    J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes with the epicholorohydrin-modified porcine aortic heart valve: a 15-year follow-up.
    Wei X; Yi W; Chen W; Ma X; Lau WB; Wang H; Yi D
    Ann Thorac Surg; 2010 May; 89(5):1417-24. PubMed ID: 20417754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six years' experience with the Omnicarbon valve prosthesis.
    Otaki M; Kitamura N
    Cardiovasc Surg; 1993 Oct; 1(5):594-8. PubMed ID: 8076103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mitroflow pericardial bioprosthesis. Comparison of early clinical performance in aortic and mitral positions.
    Jamieson WR; Pelletier LC; Gerein AN; Pomar J
    Can J Surg; 1992 Apr; 35(2):159-64. PubMed ID: 1562925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.
    O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F
    J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carpentier-Edwards bioprosthesis: a 7-year follow-up in 361 patients.
    Zussa C; Del Ponte S; Ottino GM; Pansini S; Zattera G; Morea M
    Thorac Cardiovasc Surg; 1986 Aug; 34(4):252-7. PubMed ID: 2429394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mitroflow pericardial valve: clinical performance to 10 years.
    Mazzucotelli JP; Bertrand PC; Loisance DY
    J Heart Valve Dis; 1995 Jul; 4(4):407-13. PubMed ID: 7582152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
    Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.